<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-07-02T07:22:13Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7578" metadataPrefix="dim">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7578</identifier><datestamp>2023-03-23T01:05:15Z</datestamp><setSpec>com_10259_6256</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_6257</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="16276ee1-055a-40d4-a68f-43a24bde4210" confidence="600" orcid_id="">Fernández-Lázaro, Diego</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="e0753cdf-9ba7-42f9-b316-53b54cb4bbe4" confidence="600" orcid_id="">Seco-Calvo, Jesús</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="8345dbf1-7409-4e45-8aad-c2b087633f38" confidence="600" orcid_id="">Pascual-Fernández, Jorge</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="96cfd1f5-00dc-4565-8520-343d86d0facc" confidence="600" orcid_id="">Domínguez-Ortega, Carlos</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="c66c2446-c69b-4bcb-9f2a-825810ee6d2a" confidence="600" orcid_id="">Valle Soto, Miguel del</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="627" confidence="600" orcid_id="0000-0002-6554-4602">Mielgo Ayuso, Juan</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2023-03-22T07:43:23Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2023-03-22T07:43:23Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2022-12</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10259/7578</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="doi">10.3390/ijerph192316158</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="essn">1660-4601</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="en">Tribulus terrestris L. (TT) ingredients have anti-inflammatory and antioxidant activities,&#xd;
but their effects on exercise-induced muscle damage (EIMD) in trained athletes are uncertain. The&#xd;
purpose of this single-blind placebo-controlled trial, in accordance with CONSORT guidelines,&#xd;
was to examine the effect of 6 weeks of TT supplementation on muscle metabolism, inflammation&#xd;
biomarkers, and oxidant status. Thirty trained male CrossFit® athletes were randomly assigned to be&#xd;
supplemented with 770 mg/day of TT (intervention group (IG)) or receive a placebo daily (control&#xd;
group (CG)) for 6 weeks. Muscle damage enzymes, inflammation biomarkers, and Total Antioxidant&#xd;
Status (TAS) were assessed at baseline (T1), 21 days after baseline (T2), and after 42 days (T3). Grace, a&#xd;
Workout of the Day, was measured in T1 and T3. Statistical significance (p &lt; 0.05) was found between&#xd;
IG and CG in Lactate Dehydrogenase (LDH), C-reactive protein (CRP), and TAS levels at the end of&#xd;
the follow-up. Furthermore, TAS levels were significantly (p &lt; 0.05) lower at T2 and T3 relative to&#xd;
baseline in the IG, also LDH and CRP increased significantly (p &lt; 0.05) at T2 and T3 relative to baseline&#xd;
in the CG. No significant (p > 0.05) decreases in muscle damage or inflammation biomarkers were&#xd;
observed, although a slight downward trend was observed after 6 weeks for supplemented athletes.&#xd;
TT supplementation could attenuate the CrossFit® training program-induced oxidative stress, muscle&#xd;
damage, and inflammation which could be due to the natural antioxidant and anti-inflammatory&#xd;
properties of TT.</dim:field>
<dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso" lang="es">eng</dim:field>
<dim:field mdschema="dc" element="publisher" lang="en">MDPI</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="ispartof" lang="en">International Journal of Environmental Research and Public Health. 2022, V. 19, n. 23, 16158</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="publisherversion" lang="es">https://doi.org/10.3390/ijerph192316158</dim:field>
<dim:field mdschema="dc" element="rights" lang="*">Atribución 4.0 Internacional</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri" lang="*">http://creativecommons.org/licenses/by/4.0/</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="es">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Tribulus terrestris L.</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Herbal supplementation</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Crossfit</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Muscle damage</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Inflammation response</dim:field>
<dim:field mdschema="dc" element="subject" lang="en">Exercise-induced oxidative stress</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="es">Fisiología</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="other" lang="en">Physiology</dim:field>
<dim:field mdschema="dc" element="title" lang="en">6-Week Supplementation with Tribulus terrestris L. to Trained Male CrossFit® Athletes on Muscle, Inflammation, and Antioxidant Biomarkers: A Randomized, Single-Blind, Placebo-Controlled Trial</dim:field>
<dim:field mdschema="dc" element="type" lang="es">info:eu-repo/semantics/article</dim:field>
<dim:field mdschema="dc" element="type" qualifier="hasVersion" lang="es">info:eu-repo/semantics/publishedVersion</dim:field>
<dim:field mdschema="dc" element="journal" qualifier="title" lang="en">International Journal of Environmental Research and Public Health</dim:field>
<dim:field mdschema="dc" element="volume" qualifier="number" lang="es">19</dim:field>
<dim:field mdschema="dc" element="issue" qualifier="number" lang="es">23</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>